Prothena Corporation plc

PRTA Stock Healthcare Biotechnology
$8.35
-0.15 (-1.76%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-1.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-18.3%

Own PRTA?

See how PRTA contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.